CN108383822B - 2-氯-1-(6-氟-3,4-二氢-2h-1-苯并吡喃-2-基)乙酮的制备方法 - Google Patents
2-氯-1-(6-氟-3,4-二氢-2h-1-苯并吡喃-2-基)乙酮的制备方法 Download PDFInfo
- Publication number
- CN108383822B CN108383822B CN201810151787.XA CN201810151787A CN108383822B CN 108383822 B CN108383822 B CN 108383822B CN 201810151787 A CN201810151787 A CN 201810151787A CN 108383822 B CN108383822 B CN 108383822B
- Authority
- CN
- China
- Prior art keywords
- dihydro
- fluoro
- reagent
- benzopyran
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- JOIVVMUMDLHKRF-UHFFFAOYSA-N 2-chloro-1-(6-fluoro-3,4-dihydro-2h-chromen-2-yl)ethanone Chemical compound O1C(C(=O)CCl)CCC2=CC(F)=CC=C21 JOIVVMUMDLHKRF-UHFFFAOYSA-N 0.000 title claims abstract description 11
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- 239000011701 zinc Substances 0.000 claims abstract description 27
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000010791 quenching Methods 0.000 claims abstract description 18
- 230000000171 quenching effect Effects 0.000 claims abstract description 16
- JPIYTTJQYJXVCA-UHFFFAOYSA-N Fc1ccc2OC(CCc2c1)C#N Chemical compound Fc1ccc2OC(CCc2c1)C#N JPIYTTJQYJXVCA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 52
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 27
- 238000003756 stirring Methods 0.000 claims description 25
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 21
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical group [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 20
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 239000012265 solid product Substances 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 238000002390 rotary evaporation Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000009776 industrial production Methods 0.000 abstract description 6
- -1 pyran-2-yl Chemical group 0.000 abstract description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical class CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000047 product Substances 0.000 description 17
- 238000001816 cooling Methods 0.000 description 13
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 description 10
- 235000019270 ammonium chloride Nutrition 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000005457 ice water Substances 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- 238000010025 steaming Methods 0.000 description 9
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- 238000010606 normalization Methods 0.000 description 8
- JWEXHQAEWHKGCW-BIISKSHESA-N (R,S,S,S)-nebivolol hydrochloride Chemical compound Cl.C1CC2=CC(F)=CC=C2O[C@H]1[C@@H](O)CNC[C@H](O)[C@H]1OC2=CC=C(F)C=C2CC1 JWEXHQAEWHKGCW-BIISKSHESA-N 0.000 description 6
- ZNJANLXCXMVFFI-UHFFFAOYSA-N 6-fluoro-3,4-dihydro-2h-chromene-2-carboxylic acid Chemical compound FC1=CC=C2OC(C(=O)O)CCC2=C1 ZNJANLXCXMVFFI-UHFFFAOYSA-N 0.000 description 6
- 229940068174 nebivolol hydrochloride Drugs 0.000 description 6
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- KOHIRBRYDXPAMZ-YHBROIRLSA-N (S,R,R,R)-nebivolol Chemical compound C1CC2=CC(F)=CC=C2O[C@H]1[C@H](O)CNC[C@@H](O)[C@H]1OC2=CC=C(F)C=C2CC1 KOHIRBRYDXPAMZ-YHBROIRLSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229960000619 nebivolol Drugs 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010007558 Cardiac failure chronic Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 1
- PJGJQVRXEUVAFT-UHFFFAOYSA-N chloroiodomethane Chemical compound ClCI PJGJQVRXEUVAFT-UHFFFAOYSA-N 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000007257 deesterification reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- VQEVKEKJZVEGPH-UHFFFAOYSA-N lithium;chloromethane Chemical compound [Li+].Cl[CH2-] VQEVKEKJZVEGPH-UHFFFAOYSA-N 0.000 description 1
- CQRPUKWAZPZXTO-UHFFFAOYSA-M magnesium;2-methylpropane;chloride Chemical compound [Mg+2].[Cl-].C[C-](C)C CQRPUKWAZPZXTO-UHFFFAOYSA-M 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810151787.XA CN108383822B (zh) | 2018-02-14 | 2018-02-14 | 2-氯-1-(6-氟-3,4-二氢-2h-1-苯并吡喃-2-基)乙酮的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810151787.XA CN108383822B (zh) | 2018-02-14 | 2018-02-14 | 2-氯-1-(6-氟-3,4-二氢-2h-1-苯并吡喃-2-基)乙酮的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108383822A CN108383822A (zh) | 2018-08-10 |
CN108383822B true CN108383822B (zh) | 2020-09-18 |
Family
ID=63069128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810151787.XA Active CN108383822B (zh) | 2018-02-14 | 2018-02-14 | 2-氯-1-(6-氟-3,4-二氢-2h-1-苯并吡喃-2-基)乙酮的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108383822B (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102127061B (zh) * | 2010-01-15 | 2016-02-17 | 浙江华海药业股份有限公司 | 一种制备6-氟-3,4-二氢-2h-1-苯并吡喃-2-环氧乙烷的改进方法 |
-
2018
- 2018-02-14 CN CN201810151787.XA patent/CN108383822B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108383822A (zh) | 2018-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114409515B (zh) | 一种偕二氟烯烃化合物的制备方法 | |
CN113402511B (zh) | 一种苯唑草酮的制备方法 | |
CN108358868B (zh) | 2-取代苯并噻唑类化合物的制备方法 | |
CN108383822B (zh) | 2-氯-1-(6-氟-3,4-二氢-2h-1-苯并吡喃-2-基)乙酮的制备方法 | |
JP5578809B2 (ja) | 3−メチル−2−チオフェンカルボン酸の製造方法 | |
CN117327016A (zh) | 一种砜吡草唑中间体的制备方法 | |
CN111925330A (zh) | 一种阿替美唑的制备方法 | |
CN113501771B (zh) | 一种n-(2-氨乙基)甘氨酸衍生物的制备方法 | |
CN110498744B (zh) | 一种1-乙基-3-硝基苯的制备方法 | |
CN110330422B (zh) | 一种2,6-二乙基-4-甲基苯乙酸的制备方法 | |
CN113354521A (zh) | 一种2-甲氧基-5-氟溴代苯乙酮的制备方法 | |
CN112707860A (zh) | 活性中间体4-氯-3-硝基吡啶的合成方法 | |
CN104557512B (zh) | 一种3-(溴代苯基)-2,2’-二氟丙酸的制备方法 | |
CN116023359B (zh) | 一种氨基噻吩类化合物的合成方法及氨基噻吩类化合物 | |
CN110642818B (zh) | 一种制备苯并呋喃-2-甲酰胺类化合物的方法 | |
CN110028437B (zh) | 一种微波促进制备2-苯基-3-醛基吲哚类化合物的方法 | |
CN111170946B (zh) | 一种奥美沙坦中间体的合成方法 | |
CN113387874B (zh) | 6,6-二烷基哌啶-2-羧酸化合物的合成方法 | |
CN110590641B (zh) | 一种3-羟基异吲哚-1-酮系列化合物的绿色制备方法 | |
CN109942590B (zh) | 一种氯化两面针碱的制备方法 | |
CN107162999B (zh) | 2-苯基-4-对羟基苯基噻唑的合成方法 | |
CN109053780B (zh) | 一种抗肿瘤药物Acalabrutinib关键中间体的制备方法 | |
CN111057031A (zh) | 一种苯并呋喃酮的制备方法 | |
CN118420608A (zh) | 一种砜吡草唑的制备方法 | |
CN115073308A (zh) | 1-氨甲基-1-环丙醇的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180814 Address after: 317322 Xianju County, Taizhou City, Zhejiang Province Applicant after: Zhejiang Charioteer Pharmaceutical Co., Ltd. Applicant after: Jiangsu Baju Pharmaceutical Co., Ltd. Applicant after: Zhejiang University of Technology Address before: 317322 Xianju County, Taizhou City, Zhejiang Province Applicant before: Zhejiang Charioteer Pharmaceutical Co., Ltd. |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Pu Tong Inventor after: Chen Tian Inventor after: Wang Naixing Inventor after: Wang Jiahong Inventor after: Zhang Feifei Inventor before: Chen Tian Inventor before: Wang Naixing Inventor before: Wang Jiahong Inventor before: Zhang Feifei Inventor before: Pu Tong |
|
GR01 | Patent grant | ||
GR01 | Patent grant |